AVBP fundamentals
An in-depth look to ArriVent BioPharma, Inc. operating, investing, and financing activities
AVBP free cash flow for Q4 24 is -16.15 M USD. For 2024, AVBP free cash flow was -70.21 M USD and operating cash flow was -70.21 M USD.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM